NCT00624429View on ClinicalTrials.gov

A Pilot Study Involving an Asthma Management Program for Inner-city Early Head Start Children

PHASE4UnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

January 31, 2010

Conditions
Asthma
Interventions
DRUG

Budesonide respules

Budesonide respules 0.5 mg nebulized once a day for 4 months of the study.

Trial Locations (1)

85016

RECRUITING

Phoenix Children's Hospital, Phoenix

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Phoenix Children's Hospital

OTHER